India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
Why in the news? A study on drug optimization for high blood pressure in South Asians revealed three effective combinations, improving control rates significantly, offering guidance for hypertension management in India. Overview of the Study: Conducted by the Centre for Chronic Disease Control (CCDC) in collaboration with AIIMS, India, and Imperial College, London. Focused on …
Read MoreWhy in the news? A new study suggests that semaglutide, a drug for type 2 diabetes and weight loss, may significantly reduce Alzheimer’s risk. This potential breakthrough offers a novel approach to dementia prevention alongside diabetes management, especially for high-risk populations. Study Overview and Findings: Semaglutide, the active ingredient in popular drugs for type 2 …
Read MoreWhy in the news? New research reveals how Mycobacterium tuberculosis survives in immune cells, highlighting the importance of cysteine synthases in its resistance and potential antibiotic treatment advancements. TB Bacteria’s Immune Evasion Strategies: Survival Mechanism: Mycobacterium tuberculosis (Mtb) forms clusters called tubercles in the lungs, protected by lipids. It can remain dormant in cells for …
Read MoreSyllabus: GS-3: Biotechnology ,Scientific Innovations & Discoveries Focus: India’s precision medicine sector is rapidly growing, but inadequate biobank regulations are hindering its full potential. With biobanks playing a crucial role in medical research, the need for strong data protection laws and ethical oversight has come to the forefront, pushing for reforms. Introduction to Precision Medicine …
Read MoreWhy in the news? The Nobel Prize in Physiology or Medicine 2024 went toS. scientists Victor Ambros and Gary Ruvkun for discovering microRNA, a key molecule in gene regulation. Their groundbreaking work has revolutionised understanding of how cells function and opened new avenues for medical research in cancer and other diseases. Nobel Prize Winners and …
Read More
